Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Phage “cocktail” wipes out 99% of E. coli in meat, spinach

By Drug Discovery Trends Editor | April 1, 2014

Treating food products with select bacteriophages—viruses that target and kill bacteria—could significantly reduce concentrations of E. coli, a Purdue Univ. study shows.

An injection of bacteriophages—also known informally as “phages”—nearly eradicated a toxin-producing strain of E. coli in contaminated spinach and ground beef, in some cases decreasing E. coli concentrations by about 99%.

The study suggests that bacteriophage treatment could be an effective tool to help ensure the safety of food products, said Paul Ebner, associate professor of animal sciences.

“Phage treatment is a way of harnessing the natural antibacterial properties of phages to limit E. coli and other important foodborne pathogens,” Ebner said. “Applying this kind of therapy to contaminated foods will make them safer.”

While most strains of E. coli are harmless, some can cause severe and potentially fatal illnesses. The strain used in Ebner’s study—E. coli O157:H7—caused more than 63,000 illnesses, 2,100 hospitalizations and 20 deaths in the U.S. in 2011. Ingesting as few as 10 colony-forming units of E. coli O157:H7 can result in serious illness.

 

 

Most E. coli infections are caused by eating undercooked meat contaminated with the bacteria, but outbreaks associated with fresh produce such as spinach are on the rise.

Ebner and Purdue graduate students Yingying Hong and Yanying Pan infected fresh spinach leaves and ground beef with about 10 million cells of E. coli, a far greater amount than typically found in contaminated food products, Ebner said. The researchers then treated the food with a “phage cocktail,” a liquid containing three kinds of phages selected for their ability to quickly and efficiently kill E. coli. Using a variety of phages also helps prevent the bacteria from developing resistance.

After 24 hours, the treatment had reduced E. coli concentrations in the spinach, stored at room temperature, by more than 99.9 percent. E. coli dropped by more than 99.8% and about 99.8% in spinach after 48 and 72 hours, respectively.

In ground beef stored at room temperature, the phages cleaned up about 99% of E. coli bacteria within 24 hours. The number of E. coli in refrigerated and undercooked ground beef shrunk by about 68% and 73%, respectively.

“Bacteria have viruses just like we do,” Ebner said. “We’re taking what already exists in nature and concentrating it to have an impact on these bacteria.”

The search-and-destroy methods of phages sound like the stuff of science fiction: Spaceship-like phages dock onto the receptor sites of a host bacterium cell and deploy a syringe-like device that penetrates the cell wall. They inject their own DNA into the host cell, transforming it into a phage-making factory. The cell assembles phages until it contains so many it explodes, releasing the next generation of phages to find new hosts.

“Phages are the most abundant life forms on the planet—if you consider viruses to be alive,” Ebner said. “You can eat thousands of phages just by licking your lips.”

Ingesting phages does not pose a threat to human health because phages are highly host-specific, only targeting certain types of bacteria, said Ebner.

“Phage therapy is a way of using microbes beneficially, similar to using probiotics in yoghurt,” he said.

Interest in using phages as antibacterial treatments has increased with the rise of antibiotic-resistant bacteria. The host specificity of phages can be an advantage over broad-spectrum antibiotics, which can wipe out both pathogenic and beneficial bacteria, Ebner said.

He said phage therapy is not a substitute for antibiotics, but “it can be very effective when used at specific time points and for shorter periods.”

Development of bacteriophage treatments to reduce Escherichia coli O157:H7 contamination of beef products and produce

Source: Purdue Univ.

 

Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE